Green Cross (005250)

Currency in KRW
10,710
-640(-5.64%)
Closed·
005250 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
10,66011,150
52 wk Range
9,58018,010
Key Statistics
Bid/Ask
10,700.00 / 10,710.00
Prev. Close
11,350
Open
11,140
Day's Range
10,660-11,150
52 wk Range
9,580-18,010
Volume
225.38K
Average Volume (3m)
360.71K
1-Year Change
-36.25%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
005250 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low Price / Book multiple

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
18/05/2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -1,978.21%
Dividend Yield
2.64%
Industry Median 1.01%
Annualised payout
300.00
Paid annually
5-Years Growth
-
Growth Streak

Compare 005250 to Peers and Sector

Metrics to compare
005250
Peers
Sector
Relationship
P/E Ratio
−5.5x8.4x−0.5x
PEG Ratio
0.03−0.110.00
Price/Book
0.6x1.6x2.6x
Price / LTM Sales
0.2x4.9x3.0x
Upside (Analyst Target)
-46.5%58.6%
Fair Value Upside
Unlock20.2%10.2%Unlock

GC Corp. operates as a biotechnology company. The company provides prescription drugs and over-the-counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and varicella; recombinant treatments for acquired thrombotic thrombocytopenic purpura, fabry, hemophilia, hunterase, colon cancer, and hunter syndrome; and small molecules for gangliosidosis andalagille’s syndrome. The company has partnerships and collaborations with biotech companies and academia for development of new drugs and technologies, and clinical trials. Additionally, the company provides personalized nutrition injections. The company was formerly known as Green Cross Holdings Corporation and changed its name to GC Corp. in April 2026. The company was founded in 1967 and is headquartered in Yongin-Si, South Korea.

Employees
144

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
2.91M6.40%32.99B
Other Institutional Investors
12.73M28.04%144.51B
Public Companies & Retail Investors
29.76M65.55%337.81B
Total
45.4M100.00%515.31B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
MOGAM Biotechnology Research Institute9.04%4,102,19046,559,857
The National Pension Fund6.15%2,791,54931,684,081

People Also Watch

47,800
001430
+3.13%
946,000
003240
+4.88%
37,850
001440
+2.44%
40,300
007340
+0.88%
53,900
082740
+7.58%

FAQ

What Is the Green Cross (Seoul: 005250) Share Price Today?

The Green Cross stock price today is 10,710 KRW.

What Stock Exchange Does Green Cross (005250) Trade On?

Green Cross is listed and trades on the Seoul Stock Exchange.

What Is the Ticker (Stock Symbol) for Green Cross?

The stock symbol (also called a 'ticker') for Green Cross is "005250."

Does Green Cross Pay Dividends? What’s The Current 005250 Dividend Yield?

Yes, 005250 Pays Dividends to its Shareholders. The current Green Cross dividend yield is 2.8%.

What Is the Current Green Cross Market Capitalisation?

As of today, Green Cross (Seoul: 005250) market cap is 488.57B KRW.

What Is Green Cross's (005250) Earnings Per Share (TTM)?

The Green Cross EPS is currently -1,978 (Trailing Twelve Months).

When Is the Next Green Cross Earnings Date?

Green Cross's next earnings report will be released on 18/08/2026.

Is 005250 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Green Cross moving averages and other technical indicators, the daily buy/sell signal for 005250 stock is Strong Sell.

How Many Times Has Green Cross Stock Split?

Green Cross has split 9 times. (See the 005250 stock split history page for full effective split date and price information.)

How Many Employees Does Green Cross Have?

Green Cross has 144 employees, based on their latest Companies House report.

What is the current trading status of Green Cross (Seoul: 005250)?

As of 12/06/2026, Green Cross (005250) is trading at a share price of 10,710 KRW, with a previous close of 11,350 KRW. The stock has fluctuated within a day range of 10,660 KRW to 11,150 KRW, while its 52-week range spans from 9,580 KRW to 18,010 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.